AbbVie Inc.’s Allergan and its Korean partner Medytox Inc. won the first round of a U.S. trade dispute in which they are trying to block imports of Evolus Inc.’s Jeuveau, a rival to the Botox wrinkle treatment.
A U.S. trade judge investigating claims that Jeuveau was developed using stolen trade secrets found against Evolus and its partner, Daewoong Pharmaceutical Co., and has recommended a 10-year ban on Jeuveau imports, the companies said in statements.
Evolus Botox Rival Loses First Round Over AbbVie’s Allergan
Hi, great article. I myself used Botox and was very afraid before the first injections, because I had seen enough of very bad results on the Internet. But thank God I came across excellent masters and everything went at the highest level!